These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17661831)

  • 1. Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients.
    Kanno Y; Okada H; Kobayashi T; Takenaka T; Suzuki H
    Ther Apher Dial; 2007 Aug; 11(4):262-5. PubMed ID: 17661831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease.
    Korabecna M; Opatrna S; Wirth J; Rulcova K; Eiselt J; Sefrna F; Horinek A
    Ann N Y Acad Sci; 2008 Aug; 1137():296-301. PubMed ID: 18837963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A in chronic kidney disease.
    Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
    Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food-associated estrogenic compounds induce estrogen receptor-mediated luciferase gene expression in transgenic male mice.
    Ter Veld MG; Zawadzka E; van den Berg JH; van der Saag PT; Rietjens IM; Murk AJ
    Chem Biol Interact; 2008 Jul; 174(2):126-33. PubMed ID: 18501883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
    de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
    Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of 5-s-cysteinyldopa are correlated with skin colors in hemodialysis patients but not in peritoneal dialysis patients.
    Murakami K; Nakanishi Y; Wakamatsu K; Yamamoto K; Kohriyama N; Hasegawa M; Tomita M; Nabeshima K; Hiki Y; Asano S; Kawashima S; Ito Y; Fujita Y; Asada H; Nakai S; Sugiyama S; Ito S
    Blood Purif; 2009; 28(3):209-15. PubMed ID: 19648740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural anti-alpha-galactosyl antibodies in patients undergoing peritoneal dialysis and hemodialysis.
    Pérez Fontán M; Máñez R; Blanco F; Rodríguez-Carmona A
    Adv Perit Dial; 2000; 16():216-8. PubMed ID: 11045297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients.
    Noshad H; Sadreddini S; Nezami N; Salekzamani Y; Ardalan MR
    Singapore Med J; 2009 Feb; 50(2):185-92. PubMed ID: 19296035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the mutagenic and estrogenic activities of bisphenol A upon treatment with nitrite.
    Masuda S; Terashima Y; Sano A; Kuruto R; Sugiyama Y; Shimoi K; Tanji K; Yoshioka H; Terao Y; Kinae N
    Mutat Res; 2005 Aug; 585(1-2):137-46. PubMed ID: 15936980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients.
    Aslam N; Bernardini J; Fried L; Burr R; Piraino B
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1226-33. PubMed ID: 17699352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis-related systemic microinflammation is associated with specific genomic patterns.
    Zaza G; Pontrelli P; Pertosa G; Granata S; Rossini M; Porreca S; Staal FJ; Gesualdo L; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 2008 May; 23(5):1673-81. PubMed ID: 18048420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
    Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
    Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrition supplements in dialysis patients: use in peritoneal dialysis patients and diabetic patients.
    Poole R; Hamad A
    Adv Perit Dial; 2008; 24():118-24. PubMed ID: 18986015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal bisphenol A affects the behavior and SRC-1 expression of male pups but does not influence on the thyroid hormone receptors and its responsive gene.
    Xu X; Liu Y; Sadamatsu M; Tsutsumi S; Akaike M; Ushijima H; Kato N
    Neurosci Res; 2007 Jun; 58(2):149-55. PubMed ID: 17412439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of bisphenol A in hemodialysis patients.
    Murakami K; Ohashi A; Hori H; Hibiya M; Shoji Y; Kunisaki M; Akita M; Yagi A; Sugiyama K; Shimozato S; Ito K; Takahashi H; Takahashi K; Yamamoto K; Kasugai M; Kawamura N; Nakai S; Hasegawa M; Tomita M; Nabeshima K; Hiki Y; Sugiyama S
    Blood Purif; 2007; 25(3):290-4. PubMed ID: 17622711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.